Valuation: Molecure S.A.

Market Cap 124M 33.19M 29.01M 26.66M 24.85M 47.14M 3.16B 47.86M 320M 1.55B 125M 122M 5.35B P/E 2025 *
-
P/E 2026 * -
Enterprise Value 93.54M 24.95M 21.81M 20.04M 18.68M 35.44M 2.38B 35.97M 241M 1.17B 93.65M 91.64M 4.02B EV / Sales 2025
19.2x
EV / Sales 2026 * 9.8x
Free-Float
70.71%
Yield 2025 *
-
Yield 2026 * -
1 day+3.78%
1 week+8.05%
Current month+9.82%
1 month+0.17%
3 months+14.39%
6 months-13.09%
Current year-8.48%
1 week 5.38
Extreme 5.38
6.1
1 month 5.25
Extreme 5.25
6.12
Current year 4.98
Extreme 4.98
9.04
1 year 4.98
Extreme 4.98
9.06
3 years 4.98
Extreme 4.98
25.5
5 years 4.98
Extreme 4.98
49.95
10 years 4.98
Extreme 4.98
80.4
Manager TitleAgeSince
Chief Executive Officer - 2012-11-30
Director of Finance/CFO - -
Chief Tech/Sci/R&D Officer - 2023-01-02
Director TitleAgeSince
Director/Board Member - 2021-06-29
Chairman 38 2023-05-31
Director/Board Member - 2022-01-13
Date Insider Type Main position Quantity % Market Cap.
23-12-21Buy

Chief Executive Officer

49,000 0.2910%
Change 5-day change 1-year change 3-year change Capi.($)
+3.78%+8.05%0.00%-68.87% 33.19M
+0.68%+5.92%+77.86%+136.97% 59.1B
+2.32%+5.03%+75.26%+92.31% 55.19B
+3.86%+6.93%-11.32%-10.57% 24.67B
+4.30%+7.95%+14.11%+440.44% 24.19B
+4.74%+13.68%+43.36%-3.82% 19.69B
-0.29%+9.78%+43.90%-29.12% 17.56B
0.00%+20.78%+186.15%+347.42% 16.22B
+6.72%+19.38%+37.85% - 14.84B
+3.50%+1.97%+21.02%+193.33% 14.04B
Average +2.96%+8.52%+48.82%+122.01% 24.55B
Weighted average by Cap. +2.46%+6.47%+58.32%+135.87%

Financials

2025 2026 *
Net sales 3.9M 1.04M 909K 836K 779K 1.48M 99.04M 1.5M 10.03M 48.68M 3.9M 3.82M 168M 13.1M 3.49M 3.05M 2.81M 2.62M 4.96M 333M 5.04M 33.7M 164M 13.11M 12.83M 563M
Net income -21.2M -5.65M -4.94M -4.54M -4.23M -8.03M -538M -8.15M -54.53M -265M -21.22M -20.77M -912M -71.6M -19.1M -16.69M -15.34M -14.3M -27.12M -1.82B -27.54M -184M -894M -71.68M -70.14M -3.08B
Net Debt -30.9M -8.24M -7.2M -6.62M -6.17M -11.71M -785M -11.88M -79.49M -386M -30.93M -30.27M -1.33B 3.9M 1.04M 909K 836K 779K 1.48M 99.04M 1.5M 10.03M 48.68M 3.9M 3.82M 168M
Logo Molecure S.A.
Molecure SA, formerly known as Oncoarendi Therapeutics SA, is a Poland-based biopharmaceutical company. The Company is dedicated to discovering, developing and commercializing therapeutics for neoplastic and inflammatory diseases. The Company's business model is focused on drug discovery and development, with its core strength in medicinal chemistry and preclinical biology, enhanced by scientific collaborations in specific disease areas. The Company has a platform of 3 distinct small molecule programs targeting chitinases hydrolytic enzymes with potential utility in diverse inflammatory and fibrotic diseases of high unmet medical need. Additionally, it has initiated a program focused on development of small molecule immune modulators to stop the ability of tumors to escape immune surveillance.
Employees
71
Date Price Change Volume
26-07-03 PLN 6.040 +3.78% 211,240
26-07-02 PLN 5.820 +6.01% 70,840
26-07-01 PLN 5.490 -0.18% 15,744
26-06-30 PLN 5.500 +1.10% 5,812
26-06-29 PLN 5.440 -2.68% 7,309
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
6.040PLN
Average target price
12.45PLN
Spread / Average Target
+106.13%

Quarterly revenue - Rate of surprise